Thus, these findings suggest that increased expression of HMGCR in ICB-refractory tumor cells may influence immune refractory features of the tumor microenvironment (TME), such as limited infiltration of T cells into the tumor and resistance of tumor cells to CTLs. Here, HMGCR is linked to neoplasm.